AiCure: Clinical Trials

6 trials sponsored by AiCure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 4 Not applicable, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 4
Phase 42Completed 2

Follow AiCure: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Youth Ending the HIV Epidemic
aDOT-CEI - HIV/AIDS, Mobile Health
Not applicableCompletedUniversity of California, San Francisco282023-01-312024-08-26
DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men
Emtricitabine / Tenofovir Disoproxil Oral Tablet, DOT Diary mobile app - Adherence, Medication, Risk Behavior
Phase 4CompletedPublic Health Foundation Enterprises, Inc.1002019-02-012025-07-03
DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence
Emtricitabine / Tenofovir Disoproxil Oral Tablet, DOT Diary mobile app - Adherence, Medication, Risk Behavior
Phase 4CompletedPublic Health Foundation Enterprises, Inc.202018-02-282021-10-27
Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs
AiCure, AiCure with gamification - Hepatitis C, Medication Adherence
Not applicableCompletedAlbert Einstein College of Medicine112017-11-142021-09-14
Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy
AiCure monitoring and intervention - Opiate Addiction, Medication Non-adherence
Not applicableCompletedAiCure92016-08-012017-09-12
Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy.
Monitored (M+) - Stroke
Not applicableCompletedAiCure282015-03-012016-07-12

Conditions studied

Medication Adherence (4)  ·  Directly Observed Therapy (3)  ·  Behavior, Addictive (2)  ·  Patient Compliance (2)  ·  Risk-Taking (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Hepatitis C (1)  ·  Hepatitis C, Chronic (1)  ·  Liver Diseases (1)  ·  Opioid-Related Disorders (1)  ·  Reinfection (1)  ·  Stroke (1)

Interventions

Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2)  ·  Methods (1)

Countries

United States (6)

Top investigators

Susan Buchbinder, MD (2)  ·  Adam Hanina, MBA (1)  ·  Adam Hanina, MBA, MPhil (1)  ·  Alain Litwin, MD (1)  ·  Daniel Labovitz, MD (1)  ·  Julia Arnsten, MD (1)  ·  Parya Saberi, PharmD (1)

Results publications

PMID 28386037, PMID 33044687, PMID 38134037, PMID 39222964

NIH funding

R01MH109320 (2), P30MH062246 (1)